Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)

Status:
Completed

Trial end date:
2006-04-01

Target enrollment:

Participant gender:

The purpose of this study is to determine whether TTP889 prevents venous thromboembolism following surgery to repair hip fracture.

Phase 2

vTv Therapeutics